Details of the Drug

General Information of Drug (ID: DMUXAM8)

Drug Name

4D-110

Indication

Disease Entry	ICD 11	Status	REF
Choroideremia	9B61	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Rab proteins geranylgeranyltransferase component A 1 (CHM)	TTOA18V	RAE1_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04483440) Phase 1 Open-Label, Dose-Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intravitreal 4D-110 in Patients With Choroideremia. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of 4D Molecular Therapeutics